0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Pet Medication Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-30W2602
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global OTC Pet Medication Market Insights Forecast to 2028
BUY CHAPTERS

Global OTC Pet Medication Market Research Report 2025

Code: QYRE-Auto-30W2602
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Pet Medication Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

OTC Pet Medication Market

OTC Pet Medication Market

The global market for OTC Pet Medication was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Increasing pet ownership and awareness related to pet diseases or pet health have fuelled the demand for OTC pet medication. In the OTC pet medication market, companies are offering pet medicines at competitive prices through various sales channels such as drug & pharmacy stores, pet specialty stores, etc. OTC pet medications are also available through online platforms, which has become a lucrative sales channel for the OTC pet medication market.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 45%.
This report aims to provide a comprehensive presentation of the global market for OTC Pet Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Pet Medication.
The OTC Pet Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Pet Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Pet Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of OTC Pet Medication Market Report

Report Metric Details
Report Name OTC Pet Medication Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
  • Fleas & Ticks Removal
  • Pain Relief & Arthritis
  • Dewormers
  • Others
Segment by Application
  • Dogs & Cats
  • Birds
  • Fish & Reptiles
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Zymox, ChloraSeb, Sulfox, Adequan, Dechra Pharmaceuticals PLC, Nutramax Laboratories, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of OTC Pet Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the OTC Pet Medication Market report?

Ans: The main players in the OTC Pet Medication Market are Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Zymox, ChloraSeb, Sulfox, Adequan, Dechra Pharmaceuticals PLC, Nutramax Laboratories, Inc.

What are the Application segmentation covered in the OTC Pet Medication Market report?

Ans: The Applications covered in the OTC Pet Medication Market report are Dogs & Cats, Birds, Fish & Reptiles, Others

What are the Type segmentation covered in the OTC Pet Medication Market report?

Ans: The Types covered in the OTC Pet Medication Market report are Fleas & Ticks Removal, Pain Relief & Arthritis, Dewormers, Others

Recommended Reports

Pet Healthcare Markets

Pet Product Innovations

Pet Technology Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Pet Medication Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fleas & Ticks Removal
1.2.3 Pain Relief & Arthritis
1.2.4 Dewormers
1.2.5 Others
1.3 Market by Application
1.3.1 Global OTC Pet Medication Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dogs & Cats
1.3.3 Birds
1.3.4 Fish & Reptiles
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Pet Medication Market Perspective (2020-2031)
2.2 Global OTC Pet Medication Growth Trends by Region
2.2.1 Global OTC Pet Medication Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC Pet Medication Historic Market Size by Region (2020-2025)
2.2.3 OTC Pet Medication Forecasted Market Size by Region (2026-2031)
2.3 OTC Pet Medication Market Dynamics
2.3.1 OTC Pet Medication Industry Trends
2.3.2 OTC Pet Medication Market Drivers
2.3.3 OTC Pet Medication Market Challenges
2.3.4 OTC Pet Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Pet Medication Players by Revenue
3.1.1 Global Top OTC Pet Medication Players by Revenue (2020-2025)
3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2020-2025)
3.2 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC Pet Medication Revenue
3.4 Global OTC Pet Medication Market Concentration Ratio
3.4.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2024
3.5 Global Key Players of OTC Pet Medication Head office and Area Served
3.6 Global Key Players of OTC Pet Medication, Product and Application
3.7 Global Key Players of OTC Pet Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Pet Medication Breakdown Data by Type
4.1 Global OTC Pet Medication Historic Market Size by Type (2020-2025)
4.2 Global OTC Pet Medication Forecasted Market Size by Type (2026-2031)
5 OTC Pet Medication Breakdown Data by Application
5.1 Global OTC Pet Medication Historic Market Size by Application (2020-2025)
5.2 Global OTC Pet Medication Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC Pet Medication Market Size (2020-2031)
6.2 North America OTC Pet Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC Pet Medication Market Size by Country (2020-2025)
6.4 North America OTC Pet Medication Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Pet Medication Market Size (2020-2031)
7.2 Europe OTC Pet Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC Pet Medication Market Size by Country (2020-2025)
7.4 Europe OTC Pet Medication Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Pet Medication Market Size (2020-2031)
8.2 Asia-Pacific OTC Pet Medication Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC Pet Medication Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC Pet Medication Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Pet Medication Market Size (2020-2031)
9.2 Latin America OTC Pet Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC Pet Medication Market Size by Country (2020-2025)
9.4 Latin America OTC Pet Medication Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Pet Medication Market Size (2020-2031)
10.2 Middle East & Africa OTC Pet Medication Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC Pet Medication Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC Pet Medication Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer Companion Animal
11.1.1 Bayer Companion Animal Company Details
11.1.2 Bayer Companion Animal Business Overview
11.1.3 Bayer Companion Animal OTC Pet Medication Introduction
11.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2020-2025)
11.1.5 Bayer Companion Animal Recent Development
11.2 Boehringer Ingelheim Animal Health
11.2.1 Boehringer Ingelheim Animal Health Company Details
11.2.2 Boehringer Ingelheim Animal Health Business Overview
11.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
11.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2020-2025)
11.2.5 Boehringer Ingelheim Animal Health Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale OTC Pet Medication Introduction
11.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2020-2025)
11.3.5 Ceva Sante Animale Recent Development
11.4 Merck Inc.
11.4.1 Merck Inc. Company Details
11.4.2 Merck Inc. Business Overview
11.4.3 Merck Inc. OTC Pet Medication Introduction
11.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2020-2025)
11.4.5 Merck Inc. Recent Development
11.5 Zoetis Inc.
11.5.1 Zoetis Inc. Company Details
11.5.2 Zoetis Inc. Business Overview
11.5.3 Zoetis Inc. OTC Pet Medication Introduction
11.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2020-2025)
11.5.5 Zoetis Inc. Recent Development
11.6 Elanco
11.6.1 Elanco Company Details
11.6.2 Elanco Business Overview
11.6.3 Elanco OTC Pet Medication Introduction
11.6.4 Elanco Revenue in OTC Pet Medication Business (2020-2025)
11.6.5 Elanco Recent Development
11.7 Virbac SA
11.7.1 Virbac SA Company Details
11.7.2 Virbac SA Business Overview
11.7.3 Virbac SA OTC Pet Medication Introduction
11.7.4 Virbac SA Revenue in OTC Pet Medication Business (2020-2025)
11.7.5 Virbac SA Recent Development
11.8 Vetoquinol SA
11.8.1 Vetoquinol SA Company Details
11.8.2 Vetoquinol SA Business Overview
11.8.3 Vetoquinol SA OTC Pet Medication Introduction
11.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2020-2025)
11.8.5 Vetoquinol SA Recent Development
11.9 Frontline
11.9.1 Frontline Company Details
11.9.2 Frontline Business Overview
11.9.3 Frontline OTC Pet Medication Introduction
11.9.4 Frontline Revenue in OTC Pet Medication Business (2020-2025)
11.9.5 Frontline Recent Development
11.10 Zymox
11.10.1 Zymox Company Details
11.10.2 Zymox Business Overview
11.10.3 Zymox OTC Pet Medication Introduction
11.10.4 Zymox Revenue in OTC Pet Medication Business (2020-2025)
11.10.5 Zymox Recent Development
11.11 ChloraSeb
11.11.1 ChloraSeb Company Details
11.11.2 ChloraSeb Business Overview
11.11.3 ChloraSeb OTC Pet Medication Introduction
11.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2020-2025)
11.11.5 ChloraSeb Recent Development
11.12 Sulfox
11.12.1 Sulfox Company Details
11.12.2 Sulfox Business Overview
11.12.3 Sulfox OTC Pet Medication Introduction
11.12.4 Sulfox Revenue in OTC Pet Medication Business (2020-2025)
11.12.5 Sulfox Recent Development
11.13 Adequan
11.13.1 Adequan Company Details
11.13.2 Adequan Business Overview
11.13.3 Adequan OTC Pet Medication Introduction
11.13.4 Adequan Revenue in OTC Pet Medication Business (2020-2025)
11.13.5 Adequan Recent Development
11.14 Dechra Pharmaceuticals PLC
11.14.1 Dechra Pharmaceuticals PLC Company Details
11.14.2 Dechra Pharmaceuticals PLC Business Overview
11.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
11.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2020-2025)
11.14.5 Dechra Pharmaceuticals PLC Recent Development
11.15 Nutramax Laboratories, Inc.
11.15.1 Nutramax Laboratories, Inc. Company Details
11.15.2 Nutramax Laboratories, Inc. Business Overview
11.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
11.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2020-2025)
11.15.5 Nutramax Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global OTC Pet Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Fleas & Ticks Removal
 Table 3. Key Players of Pain Relief & Arthritis
 Table 4. Key Players of Dewormers
 Table 5. Key Players of Others
 Table 6. Global OTC Pet Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global OTC Pet Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global OTC Pet Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global OTC Pet Medication Market Share by Region (2020-2025)
 Table 10. Global OTC Pet Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global OTC Pet Medication Market Share by Region (2026-2031)
 Table 12. OTC Pet Medication Market Trends
 Table 13. OTC Pet Medication Market Drivers
 Table 14. OTC Pet Medication Market Challenges
 Table 15. OTC Pet Medication Market Restraints
 Table 16. Global OTC Pet Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global OTC Pet Medication Market Share by Players (2020-2025)
 Table 18. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pet Medication as of 2024)
 Table 19. Ranking of Global Top OTC Pet Medication Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by OTC Pet Medication Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of OTC Pet Medication, Headquarters and Area Served
 Table 22. Global Key Players of OTC Pet Medication, Product and Application
 Table 23. Global Key Players of OTC Pet Medication, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global OTC Pet Medication Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global OTC Pet Medication Revenue Market Share by Type (2020-2025)
 Table 27. Global OTC Pet Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global OTC Pet Medication Revenue Market Share by Type (2026-2031)
 Table 29. Global OTC Pet Medication Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global OTC Pet Medication Revenue Market Share by Application (2020-2025)
 Table 31. Global OTC Pet Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global OTC Pet Medication Revenue Market Share by Application (2026-2031)
 Table 33. North America OTC Pet Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America OTC Pet Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America OTC Pet Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe OTC Pet Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe OTC Pet Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe OTC Pet Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific OTC Pet Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific OTC Pet Medication Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific OTC Pet Medication Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America OTC Pet Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America OTC Pet Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America OTC Pet Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa OTC Pet Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa OTC Pet Medication Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa OTC Pet Medication Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Bayer Companion Animal Company Details
 Table 49. Bayer Companion Animal Business Overview
 Table 50. Bayer Companion Animal OTC Pet Medication Product
 Table 51. Bayer Companion Animal Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 52. Bayer Companion Animal Recent Development
 Table 53. Boehringer Ingelheim Animal Health Company Details
 Table 54. Boehringer Ingelheim Animal Health Business Overview
 Table 55. Boehringer Ingelheim Animal Health OTC Pet Medication Product
 Table 56. Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 57. Boehringer Ingelheim Animal Health Recent Development
 Table 58. Ceva Sante Animale Company Details
 Table 59. Ceva Sante Animale Business Overview
 Table 60. Ceva Sante Animale OTC Pet Medication Product
 Table 61. Ceva Sante Animale Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 62. Ceva Sante Animale Recent Development
 Table 63. Merck Inc. Company Details
 Table 64. Merck Inc. Business Overview
 Table 65. Merck Inc. OTC Pet Medication Product
 Table 66. Merck Inc. Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 67. Merck Inc. Recent Development
 Table 68. Zoetis Inc. Company Details
 Table 69. Zoetis Inc. Business Overview
 Table 70. Zoetis Inc. OTC Pet Medication Product
 Table 71. Zoetis Inc. Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 72. Zoetis Inc. Recent Development
 Table 73. Elanco Company Details
 Table 74. Elanco Business Overview
 Table 75. Elanco OTC Pet Medication Product
 Table 76. Elanco Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 77. Elanco Recent Development
 Table 78. Virbac SA Company Details
 Table 79. Virbac SA Business Overview
 Table 80. Virbac SA OTC Pet Medication Product
 Table 81. Virbac SA Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 82. Virbac SA Recent Development
 Table 83. Vetoquinol SA Company Details
 Table 84. Vetoquinol SA Business Overview
 Table 85. Vetoquinol SA OTC Pet Medication Product
 Table 86. Vetoquinol SA Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 87. Vetoquinol SA Recent Development
 Table 88. Frontline Company Details
 Table 89. Frontline Business Overview
 Table 90. Frontline OTC Pet Medication Product
 Table 91. Frontline Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 92. Frontline Recent Development
 Table 93. Zymox Company Details
 Table 94. Zymox Business Overview
 Table 95. Zymox OTC Pet Medication Product
 Table 96. Zymox Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 97. Zymox Recent Development
 Table 98. ChloraSeb Company Details
 Table 99. ChloraSeb Business Overview
 Table 100. ChloraSeb OTC Pet Medication Product
 Table 101. ChloraSeb Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 102. ChloraSeb Recent Development
 Table 103. Sulfox Company Details
 Table 104. Sulfox Business Overview
 Table 105. Sulfox OTC Pet Medication Product
 Table 106. Sulfox Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 107. Sulfox Recent Development
 Table 108. Adequan Company Details
 Table 109. Adequan Business Overview
 Table 110. Adequan OTC Pet Medication Product
 Table 111. Adequan Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 112. Adequan Recent Development
 Table 113. Dechra Pharmaceuticals PLC Company Details
 Table 114. Dechra Pharmaceuticals PLC Business Overview
 Table 115. Dechra Pharmaceuticals PLC OTC Pet Medication Product
 Table 116. Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 117. Dechra Pharmaceuticals PLC Recent Development
 Table 118. Nutramax Laboratories, Inc. Company Details
 Table 119. Nutramax Laboratories, Inc. Business Overview
 Table 120. Nutramax Laboratories, Inc. OTC Pet Medication Product
 Table 121. Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2020-2025) & (US$ Million)
 Table 122. Nutramax Laboratories, Inc. Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. OTC Pet Medication Picture
 Figure 2. Global OTC Pet Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Pet Medication Market Share by Type: 2024 VS 2031
 Figure 4. Fleas & Ticks Removal Features
 Figure 5. Pain Relief & Arthritis Features
 Figure 6. Dewormers Features
 Figure 7. Others Features
 Figure 8. Global OTC Pet Medication Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global OTC Pet Medication Market Share by Application: 2024 VS 2031
 Figure 10. Dogs & Cats Case Studies
 Figure 11. Birds Case Studies
 Figure 12. Fish & Reptiles Case Studies
 Figure 13. Others Case Studies
 Figure 14. OTC Pet Medication Report Years Considered
 Figure 15. Global OTC Pet Medication Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global OTC Pet Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global OTC Pet Medication Market Share by Region: 2024 VS 2031
 Figure 18. Global OTC Pet Medication Market Share by Players in 2024
 Figure 19. Global Top OTC Pet Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pet Medication as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by OTC Pet Medication Revenue in 2024
 Figure 21. North America OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America OTC Pet Medication Market Share by Country (2020-2031)
 Figure 23. United States OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe OTC Pet Medication Market Share by Country (2020-2031)
 Figure 27. Germany OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific OTC Pet Medication Market Share by Region (2020-2031)
 Figure 35. China OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America OTC Pet Medication Market Share by Country (2020-2031)
 Figure 43. Mexico OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa OTC Pet Medication Market Share by Country (2020-2031)
 Figure 47. Turkey OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE OTC Pet Medication Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Bayer Companion Animal Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 51. Boehringer Ingelheim Animal Health Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 52. Ceva Sante Animale Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 53. Merck Inc. Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 54. Zoetis Inc. Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 55. Elanco Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 56. Virbac SA Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 57. Vetoquinol SA Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 58. Frontline Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 59. Zymox Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 60. ChloraSeb Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 61. Sulfox Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 62. Adequan Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 63. Dechra Pharmaceuticals PLC Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 64. Nutramax Laboratories, Inc. Revenue Growth Rate in OTC Pet Medication Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS